Literature DB >> 17308970

The not so good effects of nitric oxide inhibition with methylene blue in cirrhosis and ascites.

Andrés Cárdenas, Michael Curry, Nezam H Afdhal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308970     DOI: 10.1007/s10620-006-9151-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Nitric oxide inhibition in cirrhosis and ascites.

Authors:  Andres Cardenas
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

2.  Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.

Authors:  Georgios Kalambokis; Michalis Economou; Andreas Fotopoulos; Jihad Al Bokharhii; Pappas Christos; Kosta Paraskevi; Papadimitriou Konstantinos; Afroditi Katsaraki; Epameinondas V Tsianos
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.

Authors:  Laurent Spahr; Pierre-Yves Martin; Emile Giostra; Michel Niederberger; Ursula Lang; Allessandro Capponi; Antoine Hadengue
Journal:  J Investig Med       Date:  2002-03       Impact factor: 2.895

4.  Methylene blue improves the hepatopulmonary syndrome.

Authors:  P Schenk; C Madl; S Rezaie-Majd; S Lehr; C Müller
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391

5.  Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.

Authors:  Helle C Thiesson; Ole Skøtt; Bente Jespersen; Ove B Schaffalitzky de Muckadell
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.